Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × Alpelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lymphangioma 2 Hyperglycemia 2 Head and Neck Squamous Cell Cancer 2 Vascular Malformations 1 Uveal Melanoma 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Diseases, Vascular 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Melanoma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Hormone Receptor Positive Breast Carcinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Exanthema 1

Interventions

Magnetic Resonance Spectroscopy 11 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Ga(III)-DOTATOC 3 Bevacizumab 3 trametinib 2 arginyllysine 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Sodium Chloride 2 Radiotherapy 2 Protons 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Imaging 2 Imatinib Mesylate 2 Gadolinium DTPA 2 Fluorodeoxyglucose F18 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631953 2024-08-06

ALTREM

Assistance Publique Hopitaux De Marseille

Phase 1 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡